The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.
about
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysisStructure and function of steroid receptor AF1 transactivation domains: induction of active conformationsHuman checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cellsEpidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptorRecognition and accommodation at the androgen receptor coactivator binding interfaceRBR E3 ubiquitin ligases: new structures, new insights, new questionsModulation of Androgen Receptor Activation Function 2 by Testosterone and DihydrotestosteroneStructural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.Minoxidil may suppress androgen receptor-related functionsTranscriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.Structural basis for computational screening of non-steroidal androgen receptor ligands.Structural and functional insights into nuclear receptor signaling.Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expressionStructural features discriminate androgen receptor N/C terminal and coactivator interactions.Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors.Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantationCoregulator control of androgen receptor action by a novel nuclear receptor-binding motif.The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.Analysis of interdomain interactions of the androgen receptor.Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator.Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection.Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.
P2860
Q24301596-76325980-EF22-4C9E-BF52-6720702AEB22Q24537137-442769E3-4A8C-4F4A-874D-7714E0023FA8Q24607572-76E8ABAE-14DC-4EBC-A8B6-0DA582E79555Q24652929-06B5C171-2EA9-445D-ADEB-2114DCB57D0CQ24799399-66F68E93-E97C-428D-B68B-788C79B129AAQ26828565-6500D86A-A071-4CB6-8031-6B15198376D0Q27646416-BEFD8ABB-1575-42E0-9382-DE952A8559DEQ27647445-0F4C000F-FB71-4B21-BED8-707B518C6029Q28258333-A2E8F073-6106-4149-B202-D17DB3533321Q30423500-E47AEF33-DD4A-4251-B26C-BE22922610E9Q33380009-FBE2C091-28CC-449C-A95C-238389944CE7Q33637010-5D6B4EE0-0E24-483A-8541-C36E643130D3Q33688566-1EE7C584-AC97-40C8-A91F-695FFD6933E7Q33967239-070A175A-0A63-4F43-9575-E1654D6D6296Q34289773-C5996206-9F08-418C-887A-8E68ED5F8068Q34348135-6C62FF4F-200E-42B0-BD84-0DEFC20ED51DQ35003769-68BEF7F3-D744-49AA-A007-8E5D211CB0E2Q35417636-3D1EAFAE-0BBA-4E88-AABC-570DA482ACBAQ36382025-F15DC799-A022-4B50-96AB-A33F6CAD6AC1Q36386200-2DB85C9B-12C2-42A3-A0F6-6FA4F434FAB5Q36803788-78BB2640-4894-4870-A5F3-BAF2B41C48DBQ37239796-284BA2D4-E343-40B4-9B01-EC9DBFFA8DC9Q37691685-BCE57E8E-EB02-4954-B4F7-F10E30D373CEQ37709925-EF44BDFF-9BD1-4F40-8BBC-18D1FFC602E5Q38076345-0E663B2A-FE3E-4E3C-B056-6A1411495D1EQ39499483-0B148341-D284-4413-B5DF-9E1B5A938B29Q41466777-590F519C-5D12-4497-A9D9-DD86FC380DF2Q43892365-3936C9DE-1245-479B-9498-C0B617BBE6BEQ44912912-A3243AC1-808C-4C18-B968-8C1C405348BBQ46882539-E9C8C23C-25A1-4E5B-AD30-98BC71F5D0AD
P2860
The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The use of phage display techn ...... nd FXXLY new signature motifs.
@ast
The use of phage display techn ...... nd FXXLY new signature motifs.
@en
type
label
The use of phage display techn ...... nd FXXLY new signature motifs.
@ast
The use of phage display techn ...... nd FXXLY new signature motifs.
@en
prefLabel
The use of phage display techn ...... nd FXXLY new signature motifs.
@ast
The use of phage display techn ...... nd FXXLY new signature motifs.
@en
P2093
P2860
P356
P1476
The use of phage display techn ...... nd FXXLY new signature motifs.
@en
P2093
Chawnshang Chang
Cheng-Lung Hsu
Huei-Ju Ting
Shuyuan Yeh
Yueh-Chiang Hu
Yuh-Ling Chen
P2860
P304
23691-23698
P356
10.1074/JBC.M211908200
P407
P577
2003-04-24T00:00:00Z